-
Ab182754-5mgLumretuzumab (anti-HER3) is a humanized anti-:HER3 (ERBB3): monoclonal antibody that can be used for the research of :cancer.Purity:>:95% (SDS-PAGE&:SEC):Endotoxin Level:<: 1.0EU/mg.
-
Ab183315-100μgPatritumab deruxtecan (anti-ERBB3) is an antibody-drug conjugate (ADC) consisting of a fully human anti-HER3 IgG1 monoclonal antibody Patritumab attached to a topoisomerase I inhibitor payload via a tetrapeptide-based cleavable linker. Patritumab
-
Ab183315-10mgPatritumab deruxtecan (anti-ERBB3) is an antibody-drug conjugate (ADC) consisting of a fully human anti-HER3 IgG1 monoclonal antibody Patritumab attached to a topoisomerase I inhibitor payload via a tetrapeptide-based cleavable linker. Patritumab
-
Ab183315-1mgPatritumab deruxtecan (anti-ERBB3) is an antibody-drug conjugate (ADC) consisting of a fully human anti-HER3 IgG1 monoclonal antibody Patritumab attached to a topoisomerase I inhibitor payload via a tetrapeptide-based cleavable linker. Patritumab
-
Ab183315-5mgPatritumab deruxtecan (anti-ERBB3) is an antibody-drug conjugate (ADC) consisting of a fully human anti-HER3 IgG1 monoclonal antibody Patritumab attached to a topoisomerase I inhibitor payload via a tetrapeptide-based cleavable linker. Patritumab
-
57692PEEK (polyetheretherketone) fingertight fittings (ferrule pack) are convenient, inert, and biocompatible. Use these fittings with 1/16 in.
-
708704-100MGApplication Takasago Ligands and Complexes for Asymmetric Reactions Legal Information Sold in collaboration with Takasago for research purposes only. WO9720789
-
708704-500MGApplication Takasago Ligands and Complexes for Asymmetric Reactions Legal Information Sold in collaboration with Takasago for research purposes only. WO9720789
-
T639045-5mgProduct introduction:The thiol-reactive :Texas Red™ C:2: maleimide: can be used to can be used to create bright red-fluorescent bioconjugates with excitation/emission maxima ∼595/615 nm.